CONDENSED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
OPERATING EXPENSES
Research and development	$ 2,943	$ 4,262	$ 5,603	$ 6,629
General and administrative	1,700	1,510	3,436	3,244
OPERATING LOSS	(4,643)	(5,772)	(9,039)	(9,873)
Finance income	215	64	440	116
NET LOSS	(4,428)	(5,708)	(8,599)	(9,757)
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	$ (4,428)	$ (5,708)	$ (8,599)	$ (9,757)
BASIC NET LOSS PER COMMON SHARE OUTSTANDING, see Note 6	$ (0.26)	$ (0.38)	$ (0.51)	$ (0.65)
DILUTED NET LOSS PER COMMON SHARE OUTSTANDING, see Note 6	$ (0.26)	$ (0.38)	$ (0.51)	$ (0.65)
Basic weighted average number of common shares outstanding	16,900,570	15,178,035	16,729,952	14,951,881
Diluted weighted average number of common shares outstanding	16,900,570	15,178,035	16,729,952	14,951,881